Having a large clinical trial portfolio means giving patients treatment options often not available anywhere else, and years before they become the standard of care. To learn more about Karmanos Cancer Institute clinical trials or to see if a trial is right for you, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment below
  • Retrospective study of outcome in genitourinary cancer patients and effects of oncology treatments on racial and ethnic disparities in patients with genitourinary cancers

    Cancer Categories
    • Genitourinary (GU)
    Karmanos Trial ID
    • 2021-067
    Age Group
    • Adult
    Scope
    • Local
    PhaseClick for Clinical Trial Phase DefinitionPhase Not Applicable
    Trials without phases (for example, studies of devices or behavioral interventions)
    • NA
    Principal Investigator

    Objective:

    Objective

    • Assess if there is an association between progression free, disease free and overall survival of patients being evaluated for or diagnosed with genitourinary (GU) cancers and racial, ethnic, molecular, pathological, radiologic and clinical patient findings and parameters
    • Evaluate the influence of systemic, surgical, radiotherapy and immune therapies on outcome of patients
    • To establish retrospective data bases to accomplish the above objectives
  • Locations

    Locations

    Karmanos Cancer Institute - Detroit Headquarters

    4100 John R
    Detroit, MI 48201
    Get Directions
    Phone: 800-527-6266